Is there a difference in clinical outcomes, inflammation, and hypermetabolism between scald and flame burn?

Pediatric Critical Care Medicine

Volumn 12, Issue 6, 2011, Pages

  Kraft, Robert ^a   Kulp, Gabriela A ^a   Herndon, David N ^a   Emdad, Fatemah ^a   Williams, Felicia N ^a   Hawkins, Hal K ^a   Leonard, Katrina R ^a   Jeschke, Marc G ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

burn injury; burn type; cytokines; morbidity; mortality; pediatric

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE;

ACUTE PHASE RESPONSE; ARTICLE; BODY SURFACE; BURN; CHILD; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HYPERMETABOLISM; INFLAMMATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REST; SCALD; SCHOOL CHILD; SEPSIS;

EID: 81155128697     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31820ac2c5     Document Type: Article

References (23)

1. Gore DC, Hawkins HK, Chinkes DL, et al: Assessment of adverse events in the demise of pediatric burn patients. J Trauma 2007; 63:814-818
2. Klein MB, Lezotte DL, Fauerbach JA, et al: The National Institute on Disability and Rehabilitation Research burn model system database: A tool for the multicenter study of the outcome of burn injury. J Burn Care Res 2007; 28:84-96
3. Rosenberg M, Robertson C, Murphy KD, et al: Neuropsychological outcomes of pediatric burn patients who sustained hypoxic episodes. Burns 2005; 31:883-889
4. Murphy KD, Lee JO, Herndon DN: Current pharmacotherapy for the treatment of severe burns. Expert Opin Pharmacother 2003; 4:369-384
5. Thomas S, Wolf SE, Chinkes DL, et al: Recovery from the hepatic acute phase response in the severely burned and the effects of long-term growth hormone treatment. Burns 2004; 30:675-679
6. Herndon DN, Tompkins RG: Support of the metabolic response to burn injury. Lancet 2004; 363:1895-1902
7. Barret JP, Herndon DN: Plantar burns in children: Epidemiology and sequelae. Ann Plast Surg 2004; 53:462-464
8. Gore DC, Chinkes DL, Wolf SE, et al: Quantification of protein metabolism in vivo for skin, wound, and muscle in severe burn patients. JPEN J Parenter Enteral Nutr 2006; 30:331-338
9. Mlcak RP, Jeschke MG, Barrow RE, et al: The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg 2006; 244:121-130
10. Hart DW, Wolf SE, Mlcak R, et al: Persistence of muscle catabolism after severe burn. Surgery 2000; 128:312-319
11. Finnerty CC, Herndon DN, Chinkes DL, et al: Serum cytokine differences in severely burned children with and without sepsis. Shock 2007; 27:4-9
12. Hayes JR, Groner JI: Using multiple imputation and propensity scores to test the effect of car seats and seat belt usage on injury severity from trauma registry data. J Pediatr Surg 2008; 43:924-927
13. D?Agostino RB Jr: Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281
14. Jeschke MG, Barrow RE, Herndon DN: Extended hypermetabolic response of the liver in severely burned pediatric patients. Arch Surg 2004; 139:641-647
15. Church D, Elsayed S, Reid O, et al: Burn wound infections. Clin Microbiol Rev 2006; 19:403-434
16. Tschop J, Martignoni A, Reid MD, et al: Differential immunological phenotypes are exhibited after scald and flame burns. Shock 2009; 31:157-163
17. Cree MG, Fram RY, Barr D, et al: Insulin resistance, secretion and breakdown are increased 9 months following severe burn injury. Burns 2009; 35:63-69
18. Cree MG, Zwetsloot JJ, Herndon DN, et al: Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg 2007; 245:214-221
19. Carter EA, Burks D, Fischman AJ, et al: Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med 2004; 14:653-658
20. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
21. Myburgh JA, Chittock DR: Differences in outcome between the NICE-SUGAR and Leuven trials: Biological mechanisms of intensive glucose control in critically ill patients. Crit Care Resusc 2009; 11:178-179
22. Preiser JC: NICE-SUGAR: The end of a sweet dream? Crit Care 2009; 13:143
23. Briassoulis G, Venkataraman S, Thompson AE: Energy expenditure in critically ill children. Crit Care Med 2000; 28:1166-1172